Literature DB >> 30532809

Acute myocardial infarction due to malignant neoplastic coronary embolus.

Naoko Kumagai1, Shin-Ichiro Miura1, Hideo Toyoshima2, Kaori Koga3, Satoshi Takeda2, Susumu Sato4, Shiho Kodama3, Masahiro Ogawa1, Kunihiro Matsuo4, Kazuki Nabeshima3, Hiroyasu Ishikura4, Kentaro Watanabe2, Keijiro Saku1.   

Abstract

A 54-year old man was diagnosed with right lung carcinoma (squamous cell carcinoma, SCC), stage IIIB (c-T2N3M0). Transthoracic echocardiography (TTE) showed a huge 8.9 cm × 1.3 cm tumor in the left atrium (LA) that was invaded by a pulmonary vein, and the tumor moved under the mitral valve at LA systole. After 3 months, he was diagnosed with acute myocardial infarction (AMI) and emergency coronary angiography (CAG) was performed. CAG showed that the distal segment of the right coronary artery was totally occluded. TTE showed that the shape of the mass tip became sharp. He was discharged on hospital day 15. He died 4 months after discharge because of right lung carcinoma with respiratory failure. An autopsy showed that the cause of AMI was tumor embolism. SCC clearly occupied a blood vessel lumen in the distal segment. This is a rare case of AMI due to embolism of lung carcinoma during progression of the disease with direct invasion to the LA. TTE is useful for assessing lung carcinoma invasion.

Entities:  

Keywords:  Acute myocardial infarction; Left atrium; Lung carcinoma; Transthoracic echocardiography; Tumor embolism

Year:  2010        PMID: 30532809      PMCID: PMC6265128          DOI: 10.1016/j.jccase.2010.05.005

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  8 in total

1.  Coronary embolism: review of the literature and presentation of fifteen cases.

Authors:  N K WENGER; S BAUER
Journal:  Am J Med       Date:  1958-10       Impact factor: 4.965

2.  Left atrial invasion by pulmonary adenocarcinoma.

Authors:  Anne Marie McLaughlin; James F Meaney; Joseph Keane; Rory A O'Donnell
Journal:  Eur J Cardiothorac Surg       Date:  2007-03-12       Impact factor: 4.191

3.  Aortic and coronary embolism of anaplastic small-cell carcinoma of the lung.

Authors:  R A Culver; P A Bampton; L P Bignold
Journal:  Med J Aust       Date:  1987-11-02       Impact factor: 7.738

Review 4.  Cardiac metastases.

Authors:  R Bussani; F De-Giorgio; A Abbate; F Silvestri
Journal:  J Clin Pathol       Date:  2006-11-10       Impact factor: 3.411

5.  Acute myocardial infarction caused by paradoxical tumorous embolism as a manifestation of hepatocarcinoma.

Authors:  O Diaz Castro; H Bueno; L A Nebreda
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

6.  Malignant neoplastic emboli to the coronary arteries: report of two cases and review of the literature.

Authors:  D M Ackermann; B A Hyma; W D Edwards
Journal:  Hum Pathol       Date:  1987-09       Impact factor: 3.466

Review 7.  Infected cardiac myxoma. Case report and literature review.

Authors:  S G Revankar; R A Clark
Journal:  Medicine (Baltimore)       Date:  1998-09       Impact factor: 1.889

8.  Myocardial infarction due to tumor embolization following pulmonary resection.

Authors:  R P Karlsberg; S S Sagel; T B Ferguson
Journal:  Chest       Date:  1978-11       Impact factor: 9.410

  8 in total
  3 in total

1.  Acute myocardial infarction caused by tumor embolus originating from upper tract urothelial carcinoma: a case report.

Authors:  Taku Yasui; Yohei Okuda; Wataru Shioyama; Toru Oka; Tatsuya Nishikawa; Risa Kamada; Koji Hatano; Kazuo Nishimura; Masashi Fujita
Journal:  Cardiooncology       Date:  2020-09-07

2.  Low ZCCHC9 Gene Expression in Peripheral Blood May Be an Acute Myocardial Infarction Genetic Molecular Marker in Patients with Stable Coronary Atherosclerotic Disease.

Authors:  Lihong Li; Heyu Meng; Xue Wang; Jianjun Ruan; Xiaomin Tian; Fanbo Meng
Journal:  Int J Gen Med       Date:  2022-02-18

3.  Lung tumor presenting with acute myocardial infarction and lower extremity arterial embolism.

Authors:  Jichun Liu; Hao Chen; Xiangrong Xie; Yuwen Yang; Shengxing Tang
Journal:  BMC Cardiovasc Disord       Date:  2020-11-11       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.